Clinical Trial Update: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

View source ↗

Summary

This update reports on a clinical trial of brentuximab vedotin in adults with CD30-positive lymphoma and indicates the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: Takeda | Conditions: Lymphoma | Status: ACTIVE_NOT_RECRUITING